Sex-related differences in subjective outcomes of mandibular advancement device treatment in adults with obstructive sleep apnea

Objective To assess short-term sex-related differences in subjective outcomes of mandibular advancement device (MAD) treatment among obstructive sleep apnea (OSA) patients. Methods This prospective longitudinal cohort study included OSA patients referred for MAD treatment at an academic dental clinic between April 2017 and August 2024. Baseline characteristics included age, sex, body mass index (BMI), apnea–hypopnea index (AHI), and patient-reported OSA-related symptoms. Follow-up evaluations documented OSA-related symptoms, treatment adherence and side effects. Sex-related differences were assessed using Mann–Whitney U test, chi-square test, and repeated logistic regression model. Results This study included 460 patients (317 [68.9%] males; median [interquartile range] age = 50 [38-59] years, BMI = 26.3 [24.2-29.0] kg/m 2 , and AHI = 14.9 [9.4-21.5] events/hour). At baseline, females were older, while BMI and AHI did not differ significantly between sexes. Both sexes most frequently reported snoring and daytime fatigue, but females reported more daytime fatigue ( P =.05) and breathing pauses during sleep ( P =.04) than males. At follow-up, all symptoms decreased ( P <.01), without significant sex-related differences. Adherence was similar between sexes, but females more frequently reported difficulty keeping the MAD in the mouth ( P <.01) and dry mouth ( P =.01). Age-stratified analyses showed no significant differences in baseline symptoms, symptom improvement, adherence, or side effects. Conclusion MAD treatment was associated with reductions in subjective OSA-related symptoms in both sexes, without significant sex-related differences. However, females reported more fatigue and breathing pauses at baseline, and more side effects than males, highlighting sex-related differences in subjective treatment experiences.

Authors

Institutions

Publication Details

Journal
Sleep Medicine
Published
2026-11-13
DOI
https://doi.org/10.1016/j.sleep.2026.109363
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sex-related differences in subjective outcomes of mandibular advancement device treatment in adults with obstructive sleep apnea

Zhengfei Huang, Ning Zhou, J. Peter van Maanen, Frank Lobbezoo et al.
3 links
Sleep Medicine
Obstructive Sleep Apnea Research
article

Sex-related differences in subjective outcomes of mandibular advancement device treatment in adults with obstructive sleep apnea

Zhengfei Huang, Ning Zhou, J. Peter van Maanen, Frank Lobbezoo, Joey Chung, Jean‐Pierre T. F. Ho, Ghizlane Aarab, Marjolein A.J. van Looij, Jerryll Asin, Lisette Venekamp
article en

Abstract

Objective To assess short-term sex-related differences in subjective outcomes of mandibular advancement device (MAD) treatment among obstructive sleep apnea (OSA) patients. Methods This prospective longitudinal cohort study included OSA patients referred for MAD treatment at an academic dental clinic between April 2017 and August 2024. Baseline characteristics included age, sex, body mass index (BMI), apnea–hypopnea index (AHI), and patient-reported OSA-related symptoms. Follow-up evaluations documented OSA-related symptoms, treatment adherence and side effects. Sex-related differences were assessed using Mann–Whitney U test, chi-square test, and repeated logistic regression model. Results This study included 460 patients (317 [68.9%] males; median [interquartile range] age = 50 [38-59] years, BMI = 26.3 [24.2-29.0] kg/m 2 , and AHI = 14.9 [9.4-21.5] events/hour). At baseline, females were older, while BMI and AHI did not differ significantly between sexes. Both sexes most frequently reported snoring and daytime fatigue, but females reported more daytime fatigue ( P =.05) and breathing pauses during sleep ( P =.04) than males. At follow-up, all symptoms decreased ( P <.01), without significant sex-related differences. Adherence was similar between sexes, but females more frequently reported difficulty keeping the MAD in the mouth ( P <.01) and dry mouth ( P =.01). Age-stratified analyses showed no significant differences in baseline symptoms, symptom improvement, adherence, or side effects. Conclusion MAD treatment was associated with reductions in subjective OSA-related symptoms in both sexes, without significant sex-related differences. However, females reported more fatigue and breathing pauses at baseline, and more side effects than males, highlighting sex-related differences in subjective treatment experiences.

Sleep MedicineVol. 149
Malmö University (SE), Academic Center for Dentistry Amsterdam (NL), Noordwest Ziekenhuisgroep (NL), OLVG (NL), Amphia Ziekenhuis (NL), Amsterdam University Medical Centers (NL), Vrije Universiteit Amsterdam (NL), University of Amsterdam (NL)
Good health and well-being
Obstructive Sleep Apnea Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon